Marché européen du médicament : quelles voies pour une réduction des écarts de prix ?
Author:
Godet-Cayré Virginie
Reference13 articles.
1. ANDERSSON F., 1994, « The ditribution of pharmaceuticals in Europe - Current and future trends in wholesaling », Health Policy, 27, 271-292 2. ATELLA V., 2000, « Drug cost containment policies in Italy : are the really effective in the long-run ? The case of minimum reference price », Health Policy, 50, p. 197-218 3. BALE H.E. JR, 1998, « The conflicts between parallel trade and product access and innovation : The case of pharmaceuticals », Journal of International Economic Law, 1 (4), 637-653 4. BLOOR K. , FREEMANTLE N. , MAYNARD A. , 1996, « Lessons from international experience in controlling pharmaceutical expenditure III : regulating industry », BMJ, 313, 33 - 35 5. BURSTALL M. L. , REUBEN A. J. , REUBEN B. G. , 1999, « Pricing and Reimbursement regulation in Europe : an update on the industry perspective », Drug Information Journal, 33, 669 - 688
|
|